{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T22:14:51Z","timestamp":1774908891781,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C17683\/A12079"],"award-info":[{"award-number":["C17683\/A12079"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13045-016-0291-0","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T09:13:17Z","timestamp":1469524397000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Risk of venous thromboembolism in hospitalised cancer patients in England\u2014a cohort study"],"prefix":"10.1186","volume":"9","author":[{"given":"Sonia","family":"Ratib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex J.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim R.","family":"Card","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Grainge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,26]]},"reference":[{"key":"291_CR1","volume-title":"The prevention of venous thromboembolism in hospitalised patients","author":"House of Commons Health Committee","year":"2005","unstructured":"House of Commons Health Committee. The prevention of venous thromboembolism in hospitalised patients. London: The Stationery Office Limited; 2005. Guideline Ref ID: HOUSEOFCOMMONS2005."},{"issue":"6","key":"291_CR2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","volume":"160","author":"JA Heit","year":"2000","unstructured":"Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon W, Melton L. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160(6):809\u201315.","journal-title":"Arch Intern Med"},{"issue":"6","key":"291_CR3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","volume":"293","author":"JW Blom","year":"2005","unstructured":"Blom JW, Doggen CM, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293(6):715\u201322.","journal-title":"JAMA"},{"issue":"7","key":"291_CR4","doi-asserted-by":"crossref","first-page":"e1001275","DOI":"10.1371\/journal.pmed.1001275","volume":"9","author":"F Horsted","year":"2012","unstructured":"Horsted F, West J, Grainge MJ. Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med. 2012;9(7):e1001275.","journal-title":"PLoS Med"},{"issue":"25","key":"291_CR5","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","volume":"343","author":"HT S\u00f8rensen","year":"2000","unstructured":"S\u00f8rensen HT, Mellemkj\u00e6r L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343(25):1846\u201350.","journal-title":"N Engl J Med"},{"key":"291_CR6","doi-asserted-by":"crossref","unstructured":"The impact of venous thromboembolism on risk of death or hemorrhage in older cancer patients. J Gen Intern Med. 2007;22(3);321-6.","DOI":"10.1007\/s11606-006-0019-x"},{"issue":"5","key":"291_CR7","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3109\/10428194.2010.551572","volume":"52","author":"LA Anderson","year":"2011","unstructured":"Anderson LA, Moore SC, Gridley G, Stone BJ, Landgren O. Concomitant and antecedent deep venous thrombosis and cancer survival in male U.S. veterans. Leuk Lymphoma. 2011;52(5):764\u201370.","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"291_CR8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/sj.bjc.6605210","volume":"101","author":"A Jones","year":"2009","unstructured":"Jones A, Stockton DL, Simpson AJ, Murchison JT. Idiopathic venous thromboembolic disease is associated with a poorer prognosis from subsequent malignancy. Br J Cancer. 2009;101(5):840\u20132.","journal-title":"Br J Cancer"},{"key":"291_CR9","unstructured":"Cancer Research UK website: http:\/\/www.cancerresearchuk.org [Last accessed 16th March 2016]."},{"key":"291_CR10","unstructured":"Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. < https:\/\/www.nice.org.uk\/guidance\/CG92 >; 2009 [Last accessed 21st December 2015]."},{"issue":"7","key":"291_CR11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMoa1108898","volume":"366","author":"G Agnelli","year":"2012","unstructured":"Agnelli G, George DJ, Kakkar AK, Fisher W, Lassen MR, Mismetti P, Mouret P, Chaudhari U, Lawson F, Turpie AG, SAVE-ONCO Investigators. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med. 2012;366(7):601\u20139.","journal-title":"N Engl J Med"},{"issue":"10","key":"291_CR12","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S1470-2045(09)70232-3","volume":"10","author":"G Agnelli","year":"2009","unstructured":"Agnelli G, Gussoni G, Bianchini C, Verso M, Mandal\u00e0 M, Cavanna L, Barni S, Labianca R, Buzzi F, Scambia G, Passalacqua R, Ricci S, Gasparini G, Lorusso V, Bonizonni E, Tonato M. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. Lancet Oncol. 2009;10(10):943\u20139.","journal-title":"Lancet Oncol"},{"key":"291_CR13","first-page":"401","volume":"61","author":"Centers for Disease Controls and Prevention (CDC)","year":"2012","unstructured":"Centers for Disease Controls and Prevention (CDC). Venous thromboembolism in adult hospitalisations-Unites States, 2007-2009. MMWR Morb Mortal Wkly Rep. 2012;61:401\u20134.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"291_CR14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.thromres.2010.06.027","volume":"126","author":"R Barba","year":"2010","unstructured":"Barba R, Zapatero A, Losa JE, Marco J, Plaza S, Canora J, Casas JM. Venous thromboembolism in acutely ill hospitalized medical patients. Thromb Res. 2010;126(4):276\u20139.","journal-title":"Thromb Res"},{"key":"291_CR15","doi-asserted-by":"crossref","unstructured":"Levitan N, Dowlati A, Remick SC, Tahsildar H, Sivinski LD, Beyth R, Rimm AA. (1999) Rates of initial and recurrent thromboembolic disease among cancer patients with malignancy versus those without malignancy: risk analysis using medicare claims data.","DOI":"10.1097\/00005792-199909000-00001"},{"issue":"3","key":"291_CR16","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1200\/JCO.2005.03.8877","volume":"24","author":"AA Khorana","year":"2006","unstructured":"Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH. Thromboembolism in hospitalized neutropenic cancer Patients. J Clin Oncol. 2006;24(3):484\u201390.","journal-title":"J Clin Oncol"},{"issue":"1","key":"291_CR17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.amjmed.2005.06.058","volume":"119","author":"PD Stein","year":"2006","unstructured":"Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med. 2006;119(1):60\u20138.","journal-title":"Am J Med"},{"issue":"10","key":"291_CR18","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/cncr.23062","volume":"110","author":"AA Khorana","year":"2007","unstructured":"Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer. 2007;110(10):2339\u201346.","journal-title":"Cancer"},{"key":"291_CR19","unstructured":"Hospital episode statistics. Avaliable at http:\/\/www.hscic.gov.uk\/hes [Last accessed 16th March 2016]."},{"issue":"14","key":"291_CR20","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/archinte.167.14.1471","volume":"167","author":"FA Spencer","year":"2007","unstructured":"Spencer FA, Lessard D, Emery C, Reed G, Goldberg RJ. Venous thromboembolism in the outpatient setting. Arch Intern Med. 2007;167(14):1471\u20135.","journal-title":"Arch Intern Med"},{"issue":"Suppl 2","key":"291_CR21","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/S0049-3848(10)70024-4","volume":"125","author":"T Wun","year":"2010","unstructured":"Wun T, White RH. Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma. Thromb Res. 2010;125 Suppl 2:S96\u2013102.","journal-title":"Thromb Res."},{"key":"291_CR22","doi-asserted-by":"publisher","unstructured":"Lopez JA, Kearon C, Lee AYY. Deep Venous Thrombosis. Hematology. 2004;2004(1):439-456. doi: 10.1182\/asheducation-2004.1.439 .","DOI":"10.1182\/asheducation-2004.1.439"},{"issue":"2","key":"291_CR23","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archinte.164.2.190","volume":"164","author":"HB Otten","year":"2004","unstructured":"Otten HB, Mathijssen J, ten Cate H, Soesan M, Inghels M, Richel DJ, Prins MH. Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon. Arch Intern Med. 2004;164(2):190\u20134.","journal-title":"Arch Intern Med"},{"issue":"11","key":"291_CR24","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/archinte.162.11.1245","volume":"162","author":"JA Heit","year":"2002","unstructured":"Heit JA, O'Fallon W, Petterson TM, Lohse CM, Silverstein MD, Mohr DN, Melton LJ. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med. 2002;162(11):1245\u20138.","journal-title":"Arch Intern Med"},{"issue":"17","key":"291_CR25","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1161\/CIRCULATIONAHA.111.084467","volume":"125","author":"MAM Rogers","year":"2012","unstructured":"Rogers MAM, Levine DA, Blumberg N, Flanders SA, Chopra V, Langa KM. Triggers of hospitalization for venous thromboembolism. Circulation. 2012;125(17):2092\u20139.","journal-title":"Circulation"},{"issue":"6","key":"291_CR26","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1365-2796.2011.02473.x","volume":"271","author":"M Schmidt","year":"2012","unstructured":"Schmidt M, Horvath-Puho E, Thomsen RW, Smeeth L, S\u00f8rensen HT. Acute infections and venous thromboembolism. J Intern Med. 2012;271(6):608\u201318.","journal-title":"J Intern Med"},{"issue":"6","key":"291_CR27","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.ejca.2012.10.021","volume":"49","author":"AJ Walker","year":"2013","unstructured":"Walker AJ, Card TR, West J, Crooks C, Grainge MJ. Incidence of venous thromboembolism in patients with cancer\u2014a cohort study using linked United Kingdom databases. Eur J Cancer. 2013;49(6):1404\u201313.","journal-title":"Eur J Cancer"},{"issue":"12","key":"291_CR28","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1002\/cncr.21496","volume":"104","author":"AA Khorana","year":"2005","unstructured":"Khorana AA, Francis CW, Culakova E, Lyman GH. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer. 2005;104(12):2822\u20139.","journal-title":"Cancer"},{"issue":"4","key":"291_CR29","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/annonc\/mdp354","volume":"21","author":"M Mandal\u00e0","year":"2010","unstructured":"Mandal\u00e0 M, Barni S, Prins M, Labianca R, Tondini C, Russo L, Milesi A, Cremonesi M, Zaccanelli M, Regonesi C, Moro C, Falanga A. Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial. Ann Oncol. 2010;21(4):871\u20136.","journal-title":"Ann Oncol"},{"issue":"3","key":"291_CR30","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1538-7836.2006.01804.x","volume":"4","author":"JW Blom","year":"2006","unstructured":"Blom JW, Vanderschoot JPM, Oostindi\u00cbR MJ, Osanto S, Van Der Meer FJM, Rosendaal FR. Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage study. J Thromb Haemost. 2006;4(3):529\u201335.","journal-title":"J Thromb Haemost"},{"issue":"7","key":"291_CR31","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1182\/blood-2015-01-625582","volume":"127","author":"AJ Walker","year":"2016","unstructured":"Walker AJ, West J, Card TR, Crooks C, Kirwan CC, Grainge MJ. When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data. Blood. 2016;127(7):849\u201357.","journal-title":"Blood"},{"issue":"10","key":"291_CR32","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","volume":"111","author":"AA Khorana","year":"2008","unstructured":"Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111(10):4902\u20137.","journal-title":"Blood"},{"issue":"11","key":"291_CR33","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.6004\/jnccn.2013.0163","volume":"11","author":"MB Streiff","year":"2013","unstructured":"Streiff MB, Bockenstedt PL, Cataland SR, Chesney C, Eby C, Fanikos J, Fogerty AE, Gao S, Goldhaber SZ, Hassoun H, Hendrie P, Holmstrom B, Kuderer N, Lee JT, Millenson MM, Neff AT, Ortel TL, Siddigi T, Smith JL, Yee GC, Zakarija A, McMillan N, Naganuma M. Venous thromboembolic disease. J Natl Compr Canc Netw. 2013;11(11):1402\u201329.","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-016-0291-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T14:33:48Z","timestamp":1568212428000},"score":1,"resource":{"primary":{"URL":"http:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-016-0291-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,26]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["291"],"URL":"https:\/\/doi.org\/10.1186\/s13045-016-0291-0","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,26]]},"article-number":"60"}}